Evolving Approaches for Pharmacological Therapy of Obesity
- PMID: 39348522
- PMCID: PMC11770897
- DOI: 10.1146/annurev-pharmtox-031124-101146
Evolving Approaches for Pharmacological Therapy of Obesity
Abstract
Obesity is a global health concern. Progress in understanding the physiology of obesity and weight reduction has provided new drug targets. Development and testing of new antiobesity medications (AOMs) has the potential to quickly expand options for treatment. In this review, we briefly summarize the physiology of obesity and weight reduction, as well as medications currently approved for weight management. We highlight the increasing use of incretin and nutrient-stimulated hormone-based therapies. We conclude with an overview of AOMs progressing through the pipeline and discuss their implications for the rapidly evolving field of obesity management.
Keywords: GLP-1RA; antiobesity medications; drugs; medications; obesity; weight.
References
-
- World Health Organization. 2000. Obesity: preventing and managing the global epidemic: report of a WHO consultation. - PubMed
-
- World Obesity Federation. 2023. World Obesity Atlas. https://data.worldobesity.org/publications/?cat=19
-
- Yuen M, Lui D, Kaplan L. 2016. A systematic review and evaluation of current evidence reveals 195 obesity-associated disorders (OBAD). Obesity Week
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical